Editorial : Opioids in the time of the COVID-19 pandemic : from cellular mechanisms to public health policy

Show simple item record

dc.contributor.author John, Scott
dc.contributor.author Walwyn, David Richard
dc.contributor.author DeFea, Kathryn
dc.contributor.author Hales, Tim G.
dc.contributor.author Walwyn, Wendy
dc.date.accessioned 2024-06-21T09:28:24Z
dc.date.available 2024-06-21T09:28:24Z
dc.date.issued 2023-07-14
dc.description.abstract No abstract available. en_US
dc.description.department Graduate School of Technology Management (GSTM) en_US
dc.description.librarian am2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.uri http://www.frontiersin.org/Pharmacology en_US
dc.identifier.citation John, S., Walwyn, D.R., DeFea, K., Hales, T.G. & Walwyn, W. (2023), Editorial: Opioids in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy. Frontiers in Pharmacology 14:1251958. DOI: 10.3389/fphar.2023.1251958. en_US
dc.identifier.issn 1663-9812 (online)
dc.identifier.other 10.3389/fphar.2023.1251958
dc.identifier.uri http://hdl.handle.net/2263/96591
dc.language.iso en en_US
dc.publisher Frontiers Media en_US
dc.rights © 2023 John, Walwyn, DeFea, Hales and Walwyn. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). en_US
dc.subject Opioid use disorder en_US
dc.subject Substance use disorder en_US
dc.subject Opioid use disorder treatment en_US
dc.subject Substance use disorder treatment en_US
dc.subject COVID-19 pandemic en_US
dc.subject Coronavirus disease 2019 (COVID-19) en_US
dc.subject SDG-03: Good health and well-being en_US
dc.subject Editorial en_US
dc.title Editorial : Opioids in the time of the COVID-19 pandemic : from cellular mechanisms to public health policy en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record